TokenPost·
Merck KGaA to Sell U.S. Contract Drug Development and Manufacturing Business
The agreement would add about 1,100 employees to Lonza’s U.S. operations. The companies expect the deal to close in mid-2027.
More news
- TokenPostHong Kong Monetary Authority Enables 24/7 Tokenized Deposit Settlement
- TokenPostAguilaTrades Holds 40x Short on 93.67 BTC With $77,435 Liquidation Price
- TokenPostDeepSeek Services Face Fresh Disruption 19 Days After Major Outage
- TokenPostCFTC Chair Urges Offshore Exchange Safeguards After Binance Breach
- crypto.newsWhat can we learn from the Binance hack and recovery?
- UnchainedZachXBT Suspects Cover-Up as Tally on Suspected EU Theft Climbs to $133 Million